Clinical trials
Phase 1 Hematologic Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| He Huang | 3 |
| Anhui Provincial Hospital | 1 |
| Kai Lin Xu，MD | 1 |
| MEI HENG | 1 |
| Shenzhen Hemogen | 1 |
| Shenzhen University General Hospital | 1 |
| Xiaoyu Zhu | 1 |
| Zhejiang University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 10 |
| Neoplasms | 5 |
| Hematologic Neoplasms | 4 |
| Neoplasms by Site | 2 |
| Anemia | 1 |
| Anemia, Hemolytic | 1 |
| Anemia, Hemolytic, Congenital | 1 |
| Genetic Diseases, Inborn | 1 |
| Hemoglobinopathies | 1 |
| Leukemia | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.